Athersys News

6 High-Growth Biotech Stocks Analysts Rate As Buys

Canada OKs Osiris drug; first stem cell therapy

Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for ...

Athersys Executive Insights: FDA Feedback, Competition

Athersys, Inc. (ATHX) Misses Q1 EPS by 3c

ATHERSYS, INC / NEW Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib

Athersys Reports First Quarter 2012 Results

CLEVELAND -- Athersys, Inc. today announced its financial results for the first quarter of 2012.

Q1 2012 Athersys, Inc. Earnings Release - After Market Close

Earnings Scheduled For May 14

McDermott International, AVG Technologies Among Stocks Gapping Up Friday

NeoStem: Huge Potential In The Cell Therapy Sector

InPlay: Athersys announces meeting with FDA to discuss advancing clinical development of MultiStem for the prevention of GvHD

Athersys Announces Meeting With FDA to Discuss Advancing Clinical Development of MultiStem(R) for the Prevention of GvHD

CLEVELAND -- Athersys, Inc. announced today that a scheduled meeting with the FDA was held to discuss the results of its recently completed clinical trial involving the administration of MultiStem to patients ...

Athersys to Host First Quarter 2012 Financial Results Call

CLEVELAND -- Athersys, Inc. today announced it will release its first quarter 2012 financial results at approximately 4:00 PM (Eastern Time) on Monday, May 14, 2012, and host a conference call shortly ...

Publication in Cell Transplantation Indicates That MultiStem(R) Could be Used in Treatment of Orphan Neurological Disorders

CLEVELAND -- Athersys, Inc. announced today the publication in the scientific journal, Cell Transplantation, of an article that describes the results of a preclinical study evaluating the administration ...

Biotech Stocks Look to Benefit From JOBS Act

NEW YORK, NY-- - One major problems in recent years for emerging biotech companies has been funding for research. With the signing of the Jumpstart Our Business Startups Act emerging biotech stocks will ...